EU Blow For Alzheimer’s Drug Leqembi; Eisai To Appeal

 
• By Neena Brizmohun
The Alzheimer’s disease drug Leqembi is already approved in the US, Japan, China, South Korea, Hong Kong and Israel • Source: Shutterstock

More from Product Reviews

More from Pink Sheet